vasculitis

The clinical presentation of the various vasculitides on the skin and internal organs is mostly determined by the diameter or size of the vessels mainly affected.{{cite book | last=Sunderkötter | first=Cord | title=Braun-Falco´s Dermatology | chapter=Vasculitis and Vasculopathies | publisher=Springer Berlin Heidelberg | publication-place=Berlin, Heidelberg | date=2022 | isbn=978-3-662-63708-1 | doi=10.1007/978-3-662-63709-8_64 | pages=1125–1169}} Non-specific symptoms are common and include fever, headache, fatigue, myalgia, weight loss, and arthralgia.{{cite book |last1=Luqmani |first1=Raashid |last2=Robson |first2=Joanna |last3=Suppiah |first3=Ravi |editor1-last=Davey |editor1-first=Patrick |editor2-last=Sprigings |editor2-first=David |title=Diagnosis and Treatment in Internal Medicine |date=August 2018 |publisher=Oxford University Press |isbn=978-0-19-956874-1 |pages=927–931 |url=https://books.google.com/books?id=hWFmDwAAQBAJ |access-date=8 August 2024 |chapter=272: Vasculitis}}{{cite journal | last=Jayne | first=David | title=The diagnosis of vasculitis | journal=Best Practice & Research Clinical Rheumatology | volume=23 | issue=3 | date=2009 | doi=10.1016/j.berh.2009.03.001 | pages=445–453| pmid=19508950 }}

All forms of vasculitis, even large vessel vasculitides, may cause skin manifestations. The most common skin manifestations include purpura, nodules, livedo reticularis, skin ulcers, and purpuric urticaria.{{cite journal | last1=Shavit | first1=Eran | last2=Alavi | first2=Afsaneh | last3=Sibbald | first3=R. Gary | title=Vasculitis—What Do We Have to Know? A Review of Literature | journal=The International Journal of Lower Extremity Wounds | volume=17 | issue=4 | date=2018 | issn=1534-7346 | doi=10.1177/1534734618804982 | pages=218–226| pmid=30501545 }}

There are several different etiologies for vasculitides. Although infections usually involve vessels as a component of more extensive tissue damage, they can also directly or indirectly cause vasculitic syndromes through immune-mediated secondary events. Simple vascular thrombosis usually only affects the luminal process, but through the process of thrombus organization, it can also occasionally cause a more chronic vasculitic syndrome. The autoimmune etiologies, a particular family of diseases characterized by dysregulated immune responses that produce particular pathophysiologic signs and symptoms, are more prevalent.{{cite book | last=Seidman | first=M.A. | title=Pathobiology of Human Disease | chapter=Vasculitis | publisher=Elsevier | year=2014 | isbn=978-0-12-386457-4 | doi=10.1016/b978-0-12-386456-7.05506-4 | pages=2995–3005}}

Primary systemic, secondary, and single-organ vasculitis are distinguished using the highest classification level in the 2012 Chapel Hill Consensus Conference nomenclature.{{cite journal | last1=Jennette | first1=J. C. | last2=Falk | first2=R. J. | last3=Bacon | first3=P. A. | last4=Basu | first4=N. | last5=Cid | first5=M. C. | last6=Ferrario | first6=F. | last7=Flores-Suarez | first7=L. F. | last8=Gross | first8=W. L. | last9=Guillevin | first9=L. | last10=Hagen | first10=E. C. | last11=Hoffman | first11=G. S. | last12=Jayne | first12=D. R. | last13=Kallenberg | first13=C. G. M. | last14=Lamprecht | first14=P. | last15=Langford | first15=C. A. | last16=Luqmani | first16=R. A. | last17=Mahr | first17=A. D. | last18=Matteson | first18=E. L. | last19=Merkel | first19=P. A. | last20=Ozen | first20=S. | last21=Pusey | first21=C. D. | last22=Rasmussen | first22=N. | last23=Rees | first23=A. J. | last24=Scott | first24=D. G. I. | last25=Specks | first25=U. | last26=Stone | first26=J. H. | last27=Takahashi | first27=K. | last28=Watts | first28=R. A. | title=2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides | journal=Arthritis & Rheumatism | publisher=Wiley | volume=65 | issue=1 | date=27 December 2012 | issn=0004-3591 | doi=10.1002/art.37715 | pages=1–11 | doi-access=free| pmid=23045170 }}

{{main|Systemic vasculitis}}

Primary systemic vasculitis is categorized by the size of the vessels mainly involved. Primary systemic vasculitis includes large-vessel vasculitis, medium-vessel vasculitis, small-vessel vasculitis, and variable-vessel vasculitis.

The 2012 Chapel Hill Consensus Conference defines large vessel vasculitis (LVV) as a type of vasculitis that can affect any size artery, but it usually affects the aorta and its major branches more frequently than other vasculitides. Takayasu arteritis (TA) and giant cell arteritis (GCA) are the two main forms of LVV.{{cite journal | last=Jennette | first=J. Charles | title=Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides | journal=Clinical and Experimental Nephrology | publisher=Springer Science and Business Media LLC | volume=17 | issue=5 | date=27 September 2013 | issn=1342-1751 | doi=10.1007/s10157-013-0869-6 | pages=603–606| pmid=24072416 | pmc=4029362 }}

Medium vessel vasculitis (MVV) is a type of vasculitis that mostly affects the medium arteries, which are the major arteries that supply the viscera and their branches. Any size artery could be impacted, though. The two primary types are polyarteritis nodosa (PAN) and Kawasaki disease (KD).

Small vessel vasculitis (SVV) is separated into immune complex SVV and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a necrotizing vasculitis linked to MPO-ANCA or PR3-ANCA that primarily affects small vessels and has few or no immune deposits. AAV is further classified as eosinophilic granulomatosis with polyangiitis (EGPA), granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA).

Immune complex small vessel vasculitis (SVV) is vasculitis that primarily affects small vessels and has moderate to significant immunoglobulin and complement component deposits on the vessel wall. Normocomplementemic urticarial vasculitis (HUV) (anti-C1q vasculitis), cryoglobulinemic vasculitis (CV), IgA vasculitis (Henoch–Schönlein) (IgAV), and anti-glomerular basement membrane (anti-GBM) disease are the categories of immune complex SVV.

Variable vessel vasculitis (VVV) is a kind of vasculitis that may impact vessels of all sizes (small, medium, and large) and any type (arteries, veins, and capillaries), with no particular type of vessel being predominantly affected. This category includes Behcet's disease (BD) and Cogan's syndrome (CS).

The subset of illnesses known as secondary vasculitis are those believed to be brought on by an underlying ailment or exposure. Systemic illnesses (such as rheumatoid arthritis), cancer, drug exposure, and infection are the primary causes of vasculitis; however, there are still few factors that have a conclusively shown pathogenic relationship to the condition.{{cite journal | last1=Mahr | first1=Alfred | last2=de Menthon | first2=Mathilde | title=Classification and classification criteria for vasculitis | journal=Current Opinion in Rheumatology | publisher=Ovid Technologies (Wolters Kluwer Health) | volume=27 | issue=1 | year=2015 | issn=1040-8711 | doi=10.1097/bor.0000000000000134 | pages=1–9| pmid=25415531 | s2cid=24318541 }} Vasculitis frequently coexists with infections, and several infections, including hepatitis B and C, HIV, infective endocarditis, and tuberculosis, are significant secondary causes of vasculitis.{{cite journal | last=Suresh | first=E | title=Diagnostic approach to patients with suspected vasculitis | journal=Postgraduate Medical Journal | publisher=Oxford University Press (OUP) | volume=82 | issue=970 | date=1 August 2006 | issn=0032-5473 | doi=10.1136/pgmj.2005.042648 | pages=483–488| pmid=16891436 | pmc=2585712 }} Except for rheumatoid vasculitis, the majority of secondary vasculitis forms are exceedingly rare.{{cite journal | last1=Luqmani | first1=Raashid Ahmed | last2=Pathare | first2=Sanjay | last3=Kwok-fai | first3=Tony Lee | title=How to diagnose and treat secondary forms of vasculitis | journal=Best Practice & Research Clinical Rheumatology | publisher=Elsevier BV | volume=19 | issue=2 | year=2005 | issn=1521-6942 | doi=10.1016/j.berh.2004.11.002 | pages=321–336| pmid=15857799 }}

Single-organ vasculitis, formerly known as "localized", "limited", "isolated", or "nonsystemic" vasculitis, refers to vasculitis that is limited to one organ or organ system. Examples of this type of vasculitis include gastrointestinal, cutaneous, and peripheral nerve vasculitis.

Image:Churg-Strauss syndrome - very high mag.jpg showing a vasculitis (eosinophilic granulomatosis with polyangiitis). H&E stain.]]

File:Vasculitis FDG PET-CT.png]]

• Laboratory tests of blood or body fluids are performed for patients with active vasculitis. Their results will generally show signs of inflammation in the body, such as increased erythrocyte sedimentation rate (ESR), elevated C-reactive protein (CRP), anemia, increased white blood cell count and eosinophilia. Other possible findings are elevated antineutrophil cytoplasmic antibody (ANCA) levels and hematuria.
• Other organ functional tests may be abnormal. Specific abnormalities depend on the degree of various organs involvement. A brain SPECT can show decreased blood flow to the brain and brain damage.
• The definite diagnosis of vasculitis is established after a biopsy of involved organ or tissue, such as skin, sinuses, lung, nerve, brain, and kidney. The biopsy elucidates the pattern of blood vessel inflammation.

:*Some types of vasculitis display leukocytoclasis, which is vascular damage caused by nuclear debris from infiltrating neutrophils.{{cite web | last=Eastham | first=A Brooke W | title=Leukocytoclastic Vasculitis: Practice Essentials, Pathophysiology, Etiology |url=https://emedicine.medscape.com/article/333891-overview| website=Medscape Reference |date=12 July 2021|access-date=8 November 2019|archive-date=19 October 2019|archive-url=https://web.archive.org/web/20191019131739/https://emedicine.medscape.com/article/333891-overview|url-status=live}} Updated: 25 October 2018 It typically presents as palpable purpura. Conditions with leucocytoclasis mainly include hypersensitivity vasculitis (also called leukocytoclastic vasculitis) and cutaneous small-vessel vasculitis (also called cutaneous leukocytoclastic angiitis).

• An alternative to biopsy can be an angiogram (x-ray test of the blood vessels). It can demonstrate characteristic patterns of inflammation in affected blood vessels.
• 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)has become a widely used imaging tool in patients with suspected Large Vessel Vasculitis, due to the enhanced glucose metabolism of inflamed vessel walls.{{cite journal | title=Giant-Cell Arteritis and Polymyalgia Rheumatica | journal=New England Journal of Medicine | volume=371 | issue=17 | date=2014-10-23 | issn=0028-4793 | doi=10.1056/NEJMc1409206 | pages=1652–1653}} The combined evaluation of the intensity and the extension of FDG vessel uptake at diagnosis can predict the clinical course of the disease, separating patients with favourable or complicated progress.{{cite journal | last1=Dellavedova | first1=L. | last2=Carletto | first2=M. | last3=Faggioli | first3=P. | last4=Sciascera | first4=A. | last5=Del Sole | first5=A. | last6=Mazzone | first6=A. | last7=Maffioli | first7=L. S. | title=The prognostic value of baseline 18F-FDG PET/CT in steroid-naïve large-vessel vasculitis: introduction of volume-based parameters | journal=European Journal of Nuclear Medicine and Molecular Imaging | volume=43 | issue=2 | date=2016 | issn=1619-7070 | doi=10.1007/s00259-015-3148-9 | pages=340–348| pmid=26250689 }}
• Acute onset of vasculitis-like symptoms in small children or babies may instead be the life-threatening purpura fulminans, usually associated with severe infection.

In this table: ANA = antinuclear antibodies, CRP = C-reactive protein, ESR = erythrocyte sedimentation rate, dsDNA = double-stranded DNA, ENA = extractable nuclear antigens, RNP = ribonucleoproteins; VDRL = Venereal Disease Research Laboratory

Treatments are generally directed toward stopping the inflammation and suppressing the immune system. Typically, corticosteroids such as prednisone are used. Additionally, other immune suppression medications, such as cyclophosphamide, are considered. In case of an infection, antimicrobial agents including cephalexin may be prescribed. Affected organs (such as the heart or lungs) may require specific medical treatment intended to improve their function during the active phase of the disease.{{cn|date=June 2022}}

• Golfer's vasculitis

{{Reflist}}

{{Medical resources

| DiseasesDB = 13750

| ICD10 = {{ICD10|I|77|6|i|70}}, {{ICD10|I|80||i|80}}, {{ICD10|L|95||l|80}}, {{ICD10|M|30||m|30}}-{{ICD10|M|31||m|30}}

| ICD9 = {{ICD9|446}}, {{ICD9|447.6}}

| ICDO =

| OMIM =

| MedlinePlus =

| eMedicineSubj =

| eMedicineTopic =

| MeshID = D014657

}}

{{Diseases of the skin and appendages by morphology}}

{{Vascular diseases}}

{{Cutaneous vasculitis}}

{{Systemic connective tissue disorders}}

Category:Rheumatology

Category:Inflammations

Category:Vascular-related cutaneous conditions